TruScreen runs out of product
Delay in supplying new screening device expected to hit sales
Listed technology minnow Truscreen has warned supplies of its core cancer screening product won’t be available until the end of the year after running out of its original stock.
The company told shareholders at its annual meeting just a week ago it hoped to have its new stock of product certified
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Tim Hunter
Fri, 02 Oct 2015
Fri, 02 Oct 2015
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
TruScreen runs out of product
52097